Curs BNR — 12.11.2026 EUR 5,3459 USD 4,8155 GBP 6,3935

ANTIBIOTICE

84 articole · RSS

Antibiotice Iasi CEO Ioan Nani To Step Down On December 4
Capital Market

Antibiotice Iasi CEO Ioan Nani To Step Down On December 4

Ioan Nani, chief executive officer of state-run pharmaceutical producer Antibiotice Iasi (ATB.RO), will end is mandate agreement at his request on December 4, 2026, the company said in a report to the Bucharest Stock Exchange on Friday evening.

Loredana Frățilă-Cristescu · 31.10.2026 · 06:00 · 1 min
Antibiotice Iasi Profit Halves In 9M 2025
Capital Market

Antibiotice Iasi Profit Halves In 9M 2025

Antibiotice Iasi's net profit fell by 52% to RON42.6 million in the first nine months of 2025, from RON87.9 million in the same period last year, the pharmaceutical manufacturer said in its...

Loredana Frățilă-Cristescu · 13.11.2025 · 23:17 · 1 min
Antibiotice Iasi Shareholders Called To Discuss RON376M Investment Project In Meeting On August 26
Capital Market

Antibiotice Iasi Shareholders Called To Discuss RON376M Investment Project In Meeting On August 26

The shareholders of pharmaceutical producer Antibiotice Iasi (ATB.RO) will discuss in the Ordinary General Meeting on August 26 a RON376 million investment project in an Innova a+ research a...

Loredana Frățilă-Cristescu · 24.07.2025 · 17:31 · 1 min
Metropolitan Life Pension Fund Now Owns More Than 5% In Antibiotice Iasi
Capital Market

Metropolitan Life Pension Fund Now Owns More Than 5% In Antibiotice Iasi

Privately managed pension fund Metropolitan Life now owns more than 5% in pharmaceutical producer Antibiotice Iasi (ATB.RO), a mark it overshot on July 1, when its stake increased to 5.034%...

Loredana Frățilă-Cristescu · 07.07.2025 · 15:02 · 1 min
Antibiotice Considers Issuing Bonds On Capital Market
Capital Market

Antibiotice Considers Issuing Bonds On Capital Market

Pharmaceutical producer Antibiotice Iasi (ATB.RO), is considering issuing bonds on the Bucharest Stock Exchange to raise cash to develop the business, said Liviu Vatavu, Antibiotice executiv...

Loredana Frățilă-Cristescu · 17.03.2025 · 17:58 · 1 min
IBM Research Delegation Visits Antibiotice Iasi Plant
Capital Market

IBM Research Delegation Visits Antibiotice Iasi Plant

Officials of the research division of US’ IBM, IBM Research, have visited the pharmaceutical plant of Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, to discuss...

Loredana Frățilă-Cristescu · 07.03.2025 · 22:41 · 1 min
Pension Funds Bought Into Antibiotice Iasi Following Sale Of Part Of Infinity Capital Stake
Capital Market

Pension Funds Bought Into Antibiotice Iasi Following Sale Of Part Of Infinity Capital Stake

BCR Pensii and BRD Pensii, Pillar II private pension funds, which manage pensions for 1.4 million people, bought into pharmaceutical producer Antibiotice Iasi (ATB.RO), spending RON50 millio...

Loredana Frățilă-Cristescu · 13.01.2025 · 21:35 · 1 min
Antibiotice Iasi Ends Jan-Sept 2024 with RON511M Revenues, Up 7%. Net Profit Rises 15% To RON88M
Companies

Antibiotice Iasi Ends Jan-Sept 2024 with RON511M Revenues, Up 7%. Net Profit Rises 15% To RON88M

Romanian drug manufacturer Antibiotice Iasi, in which the Romanian state hold 53%, registered RON511 million revenues in the first nine months of 2024, up 15% annually, while net profit went...

Liviu Popescu · 15.11.2024 · 10:18 · 1 min
BET Index Of Bucharest Stock Exchange Includes Antibiotice And Premier Energy As Of Sept 23
Capital Market

BET Index Of Bucharest Stock Exchange Includes Antibiotice And Premier Energy As Of Sept 23

The BET index, the main index of the Bucharest Stock Exchange (BVB), is welcoming two new companies: Antibiotice Iasi (ATB) and Premier Energy (PE), starting September 23, 2024.

Ecaterina Craciun · 23.09.2024 · 12:50 · 3 min